For research use only. Not for therapeutic Use.
CAD031(CAT: I023948) is a novel, brain-penetrant small-molecule compound developed as a therapeutic candidate for Alzheimer’s disease and other neurodegenerative disorders. Designed to enhance neuronal energy metabolism and reduce neuroinflammation, CAD031 exhibits neuroprotective properties by promoting mitochondrial function, modulating lipid metabolism, and reducing oxidative stress. Preclinical studies have demonstrated its ability to improve memory and synaptic integrity in Alzheimer’s disease models. CAD031 is commonly used in neuroscience research to explore mechanisms of cognitive decline, neuronal resilience, and age-related brain dysfunction. Its multifunctional profile makes it a promising tool for therapeutic development.
CAS Number | 2071209-49-7 |
Synonyms | N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N-[(E)-[3-(trifluoromethoxy)phenyl]methylideneamino]acetamide |
Molecular Formula | C18H14F6N2O2 |
Purity | ≥95% |
IUPAC Name | N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N-[(E)-[3-(trifluoromethoxy)phenyl]methylideneamino]acetamide |
InChI | InChI=1S/C18H14F6N2O2/c1-11-6-7-15(12(2)8-11)26(16(27)17(19,20)21)25-10-13-4-3-5-14(9-13)28-18(22,23)24/h3-10H,1-2H3/b25-10+ |
InChIKey | VDYRRQYRYZTLJV-KIBLKLHPSA-N |
SMILES | CC1=CC(=C(C=C1)N(C(=O)C(F)(F)F)N=CC2=CC(=CC=C2)OC(F)(F)F)C |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |